Management of ovarian cancer in the renal transplant recipient with cyclophosphamide used as an immunosuppressive and antineoplastic agent

Transplant Proc. 1995 Aug;27(4):2432.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Cyclophosphamide / therapeutic use*
  • Fatal Outcome
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Failure, Chronic / surgery
  • Kidney Transplantation* / immunology
  • Middle Aged
  • Ovarian Neoplasms / complications
  • Ovarian Neoplasms / drug therapy*
  • Polycystic Kidney Diseases / surgery

Substances

  • Antineoplastic Agents
  • Immunosuppressive Agents
  • Cyclophosphamide